baber/WOPTO huggingface dataset:
Patent JP-2001505243-A (JP)
Title: 難燃性熱可塑性成形用組成物
IPC: C08L69/00
Filed: 1997-11-18
Abstract: (57)【要約】
（Ａ）１〜９７重量％の少なくとも一種類のポリカルボナート、ポリアミド、ポリエステル、ポリオレフィン或いはポリメタクリラート又は前述の熱可塑性重合体の混合物、（Ｂ）（ｂ 1 ）４０〜８０重量％の０℃未満のガラス転移温度を有するエラストマー重合体から形成されるグラフトベースと、（ｂ 2 ）（ｂ 21 ）５０〜９５重量％の式Φ
 ［但し、Ｒは炭素原子数１〜８のアルキル又は水素、Ｒ 1 は炭素原子数１〜８のアルキルで、ｎは０、１、２又は３を表す。］で表わされるビニル芳香族単量体、又はメタクリル酸メチル、或いはこれらの混合物、および（ｂ 22 ）５〜５０重量％のアクリロニトリル、メタクリロニトリル、メタクリル酸メチル、無水マレイン酸又はこれらの混合物から形成される２０〜６０重量％のグラフトから構成される１〜９７重量％の少なくとも一種類のグラフト重合体、（Ｃ）（ｃ 1 ）５０〜９５重量％の式Φで表されるビニル芳香族単量体又はメタクリル酸メチル或いはこれらの混合物、および（ｃ 2 ）５〜５０重量％のアクリロニトリル、メタクリロニトリル、メタクリル酸メチル、無水マレイン酸又はこれらの混合物から形成される１〜９７重量％の少なくとも一種類の熱可塑性共重合体、（Ｄ）１〜５０重量％のイミノホスホランを含有する難燃剤、及び（Ｅ）０〜５０重量％のその他の添加剤を含む難燃性熱可塑性成形用組成物。
Patent JP-2000502937-A (JP)
Title: 大動脈弁補綴物のサイズ決定用栓子
IPC: A61B19/00
Filed: 1997-01-02
Abstract: (57)【要約】
大動脈輪の正しいサイズを決定するために使用する、大動脈輪サイズ決定用栓子器具。本器具は、フランジ部が周囲に形成された円柱状栓子体を含む。フランジ部の少なくとも下面が非平面状かつ多曲面状形状であることにより、サイズ決定に際して輪状部に設置されたときに、大動脈弁の輪状部と相補的な形状になっている。円柱状栓子体内にハンドル接続部を設け、輪状部内に栓子器具を設置する際にこのハンドル接続部にハンドルを取り付けてもよい。本発明はまた、異なるサイズの上述の大動脈弁サイズ決定用栓子を複数用いて、輪サイズを反映する栓子が見つかるまでそれぞれを順に大動脈輪内に設置することにより、大動脈弁輪のサイズを決定するための方法を包含する。
Patent JP-2001508121-A (JP)
Title: 酸化状態にある共役重合体
IPC: H01B1/12
Filed: 1998-10-26
Abstract: (57)【要約】
酸化状態にある共役重合体は、０．４又はそれ以上のドーピングレベルを有する。かかる酸化状態においては、該重合体は導電性であり、可視光に対して透過があり、好ましくは無色である。かかるポリマーの製造方法は、重合体をチアンスレニウム過塩素酸塩のような強酸化剤と接触させる工程を含む。かかる重合体の層は、エレクトロルミネセント装置中の電極層として又はディスプレイ装置上の透明コーティングとして使用することができる。
Patent JP-2000504078-A (JP)
Title: 一体型燃料レールを有する成形吸気マニホールド用燃料噴射器固定装置
IPC: F02M35/104
Filed: 1997-01-21
Abstract: (57)【要約】
一体型燃料レール部分３２を有する成形複合材吸気マニホールド２４に燃料噴射器３０を設置する固定装置および方法であって、噴射器がまず燃料レール部分のボア４２に取り付けられ、吸気マニホールドがシリンダ・ヘッド表面２６に垂直に延びるボア３８を有するシリンダ・ヘッド表面の上に押し動かされるので、マニホールドが設置されるのと同時に燃料噴射器の先端が設置される。空気補助通路６２も、シリンダ・ヘッド内の通路６６と整合する吸気マニホールドと一体的に形成される。
Patent JP-2001506293-A (JP)
Title: シクロオレフィンコポリマーの製造方法
IPC: C08F4/60
Filed: 1997-12-16
Abstract: (57)【要約】
本発明は、モノマーの全量に対し０．１〜９９．９重量％の少なくとも１種の多環式オレフィン、モノマーの全量に対し０〜９９．９重量％の少なくとも１種の単環式オレフィン、およびモノマーの全量に対し０．１〜９９．９重量％の少なくとも１種の非環式１−オレフィンを、少なくとも１種の助触媒および歪んだ幾何学的構造を有する少なくとも１種の金属錯体を含む触媒系の存在下で重合させることによる、シクロオレフィンコポリマーの製造方法に関する。
Patent JP-H11504381-A (JP)
Title: 流動床反応炉装置の運転方法および流動床反応炉装置
IPC: C10J3/54
Filed: 1996-02-21
Abstract: (57)【要約】
流動床反応炉装置１０および該装置を運転する方法が提供される。この反応炉装置は、流動床反応室１８と、この反応室に連結され、排出ガスから固体材料を分離する粒子分離装置２６とを含む。冷却面３０を有するガス冷却装置１４が粒子分離装置に連結される。本発明によれば、粒子分離装置２６で分離された材料から固体流動床材料の流れを分岐し、前記分岐した流動床材料の流れをガス冷却装置１４へ導入するために、手段４２，４４が備えられる。粒子分離装置から固体粒子の前記第１の流れを放出させる前または後において、固体粒子の主流れから流動床材料の流れが分岐される。この固体粒子の分岐された流れは、ガス冷却時またはその前において、分離装置から排出されたガス中に導入され、これらの粒子が冷却面から付着物を機械的に除去する。
Patent JP-2001508680-A (JP)
Title: 新規デバイス
IPC: A61J3/00
Filed: 1998-01-16
Abstract: (57)【要約】
注射器に接続可能で、穿孔可能なバイアルクロージャーを突き抜けさせ、よってクロージャーに穴を開けることのできる尖らせた端部へ延びるルーエル；バイアル上に取り付け可能で、最初は導管の尖らせた端部がクロージャーの方向を指した第一の位置でルーエルを支えるルーエル支持体；駆動体の支持体に対する動きによってルーエルが動かされ、その結果、尖った端部がクロージャーに穴を開けバイアル内に入るようなルーエル駆動体を含むルーエルコネクター。ルーエルコネクターは皮下注射器のバイアルへの接続を容易にする。
Patent JP-H09508745-A (JP)
Title: 連続ページランダムアクセスメモリと、連続ページランダムアクセスメモリを使用するシステムおよび方法
IPC: G11C7/10
Filed: 1996-04-19
Abstract: (57)【要約】
入出力回路部205と、複数のロウと複数のカラムに配置されているランダムアクセスメモリセル201のアレイ202とを含むランダムアクセスメモリ200が提供される。ロウデコーダ回路部206は、ロウアドレスに応答してアクセスのためのアレイ202内のセルのロウを選択するために設けられている。カラム制御回路部207、208はその選択されたロウに沿った位置に対するアクセスを制御するために含まれており、その各位置は少なくとも１つのメモリセル201を含んでいる。カラム制御回路部207、208は、入出力回路205を通じて、その選択されたロウに沿った第１の複数の位置を逐次アクセスし、その選択されたロウに沿った第２の複数の位置を同時にアクセスするように動作可能である。補助メモリ回路部209は、第２の複数の位置と入出力回路部205との間のデータ交換をインターフェイスするために含まれており、補助メモリ回路部209は、アレイ202内の第２の複数の位置の中の対応する位置とパラレルにワードを交換し、入出力回路205とシリアルにワードを交換する。
Patent JP-2001521413-A (JP)
IPC: A61M15/00
Filed: 1998-01-21
Abstract: For discharging a medium, such as a powder, a film/foil seal (16) of a reservoir chamber (24) is pierced by a tool (40) in a first axial movement, after which the medium is suctioned via an orifice (9) in feeding a delivery flow via passageways (55) from the chamber (24). On completion of a return stroke and twisting the tool (40) relative to the reservoir body (6) a further chamber (24) may be emptied in the same way, thus enabling e.g. a pharmaceutical active substance to be administered in two individual doses as expedient for nasal treatment.
Patent JP-H11514021-A (JP)
Title: 抗エッチング瓶洗浄溶液
IPC: C11D3/02
Filed: 1997-03-20
Abstract: (57)【要約】
燐化合物、エチレンジアミン四酢酸、またはニトリロ三酢酸を含有しない高苛性アルカリ組成物に、瓶を浸漬することによって、瓶洗浄機中おける瓶の化学エッチングが最少限にされる。浸漬組成物は、水中に溶解した水酸化ナトリウムを、ポリカルボン酸結晶生長阻害剤との組合せにおいて、含有する。浸漬溶液が、アルキルポリグルコシドのような非イオン界面活性剤、ならびにグルコネート、グルコヘプトネート、またはボロヘプトネートのようなキレート化剤をさらに含有するのが好ましい。浸漬溶液は、これもまた本発明の一部を構成する液体または粉末ビルダー入り洗浄剤組成物との組み合わせによって添加することができ、または、水酸化ナトリムを含有しない添加剤パッケージを添加することもできる。これらの組成物は、有効に瓶を清浄にし、結果として曇りおよび重量損失を生じるガラスの溶解を有意に減少させる。これは、瓶洗浄装置中に形成されるシリケートスケールの量も減少させる。
Patent JP-2001502048-A (JP)
IPC: C12N9/02
Filed: 1997-04-21
Abstract: The present invention relates to biodetectors for detecting and quantifying molecules in liquid, gas, or matrices. More specifically, the present invention relates to biodetectors comprising a molecular switching mechanism to express a reporter gene upon interaction with target substances. The invention further relates to methods using such biodetectors for detecting and quantifying selected substances with high specificity and high sensitivity.
Patent JP-2000511515-A (JP)
Title: ベンゾチオフェン類、それを含む製剤、および方法
IPC: A61K31/00
Filed: 1997-05-05
Abstract: (57)【要約】
本発明は、式（Ｉ）：
 ［式中、Ｒ 1 は、水素、ヒドロキシ、Ｃ 1 −Ｃ 4 アルコキシ、−ＯＣＯＯ(Ｃ 1 −Ｃ 6 アルキル)、−ＯＣＯ(Ｃ 1 −Ｃ 6 アルキル)、−ＯＣＯAr(式中、Arは、フェニル、または場合により置換されていることのあるフェニルである)、−ＯＳＯ 2 (直鎖状のＣ 4 −Ｃ 6 アルキル)、または−ＯＳＯ 3 Ｈであり；Ｒ 2 は、Ｒ 1 、Ｃｌ、またはＦであり；（ただし、Ｒ 1 またはＲ 2 の少なくとも１つが−ＯＳＯ 3 Ｈである)；Ｒ 3 は、１−ピペリジニル、１−ピロリジニル、メチル−１−ピロリジニル、ジメチル−１−ピロリジノ、４−モルホリノ、ジメチルアミノ、ジエチルアミノ、ジイソプロピルアミノ、または１−ヘキサメチレンイミノであり；そしてｎは、２または３である］の化合物、またはその医薬的に許容ざれ得る塩もしくは溶媒和物を提供する。本発明はさらに、式（Ｉ）の化合物を含む、場合により、エストロゲンまたはプロゲスチンを含むことのある医薬組成物、並びに閉経後症候群、特に骨粗鬆症、心臓血管と関係がある病理学的状態、およびエストロゲン依存性癌の症状を軽減するための、そのような化合物の単独での、またはエストロゲンもしくはプロゲスチンと組み合わせての使用に関する。本発明の化合物はまた、女性における子宮フィブロイド疾患および子宮内膜症、並びにヒトにおける大動脈平滑筋細胞増殖、特に再狭窄を抑制するのにも有用である。
Patent JP-2002501597-A (JP)
Title: 平衡手段を備える摩耗調整装置付きクラッチ機構
IPC: F16D13/58
Filed: 1999-02-15
Abstract: (57)【要約】
カバー（２）と、圧力板（１）と、圧力板（１）によって支持される支持手段（３）と、クラッチ係合手段（４）（４１）と、カバー（２）のハウジング（２０）内に取り付けられたカセット（３０）を備えた摩耗の調整装置（３０）（２００）とを有するクラッチ機構であって、カバーが、摩耗の調整装置のカセット（３０）に起因する不均衡を補正するための少なくとも１つの予備平衡用、又は平衡用リベット（２０１）を有することを特徴とするクラッチ機構。
Patent JP-2001526020-A (JP)
Title: 振動ダンパ
IPC: H02G7/14
Filed: 1998-05-13
Abstract: (57)【要約】
長形物体用の振動ダンパが開示されており、該ダンパは、第１の螺旋となるべく形成される金属のストリップを備え、該長形物体を把持するように選定される直径を有するグリップ部を形成し、該長形物体の振動を干渉し、かつ減衰するように選定されるより直径の大きい第２の螺旋をさらに備える。また、かかる振動ダンパを製作する方法も開示されており、螺旋を製作し、かつ１個の物品の製造中に該螺旋の直径を選択的に変更することが可能な装置の使用を含む。
Patent MD-20020073-A (MD)
Title: Process for obtaining an antimicrobial preparation and utilization thereof
Inventor: KLAUS-DIETER KUHN
IPC: A61L27/54
Filed: 2002-02-13
Abstract: The invention refers to a process for obtaining an antimicrobial preparation used in medicine and veterinary medicine for treatment of local microbial infections in soft and solid tissues. Summary of the invention consists in that it is mixed an amphiphilic component, represented by sulphates, sulphamates or sulphonates, one or more antimicrobial components from the group of aminoglycosides, lincosamides or tetracyclines, one auxiliary organic and/or inorganic component and, possibly, at least one biologically active component.The obtained preparation may be used as resorbable or nonresorbable implant.Claims: 16
Patent NZ-197583-A (NZ)
Title: Composite fibrous materials
Inventor: BRIGGS P J
IPC: C03C25/00
Filed: 1981-06-30
Abstract: A fibrous composite material of essentially two-dimensional form in the form of individual fibres, sheets or layers comprising combustible fibres and lamellae of a layer mineral of size below 50 microns, a method for the manufacture of the fibrous composite materials by applying lamellae of a layer mineral to the fibres preferably from suspension followed by removal of the liquid phase of the suspension, and use of the fibrous composite materials for the fire-protection of substrates.
Patent NZ-215099-A (NZ)
Title: Enzymatic resolution of racemic 2-halopropionic acids
Inventor: KLIBANOV A M
IPC: C12P7/62
Filed: 1986-02-11
Abstract: A method of resolving racemic 2-halopropionic acids by lipase-catalyzed asymmetric esterification in an organic medium is disclosed.
Patent NZ-221065-A (NZ)
Title: Conjugates of antibodies and toxins with sulphur-containing linking groups
Inventor: BARBIERI LUIGI
IPC: C07K16/00
Filed: 1987-07-14
Abstract: New immunotoxins obtained by covalent coupling between, on the one hand, trichosantine or trichokirine as such or appropriately modified and, on the other hand, an antibody or antibody fragment, employed in its natural or correctly modified form, the said coupling being produced either through the intermediacy of a disulphide bond or through the intermediacy of a thioether bond. 
<??>The invention also relates to a process for the preparation of the said immunotoxins and to pharmaceutical compositions containing them as an active substance.
Patent NZ-222006-A (NZ)
Title: Monoclonal antibodies specific to omega-ifn
Inventor: ADOLF GUENTHER
IPC: C12N15/00
Filed: 1987-09-30
Abstract: The monoclonal antibodies react specifically with human interferon of the IFN-omega type but not with other human interferons.
Patent NZ-228576-A (NZ)
Title: Piroxicam as its alkali or alkaline earth metal salt
Inventor: CHIESI PAOLO
IPC: A61K9/06
Filed: 1989-03-31
Abstract: Aqueous pharmaceutical formulations containing the active principle piroxicam or N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxyamido-1 ,1-dioxiHY # de, are described. The compositions of the invention are particularly suited for the injectable use, both because of their tolerability degree and for the favourable pharmacokinetics profile and may be advantageously used also for the preparation of collyria or eye-washes.
Patent NZ-234845-A (NZ)
Title: Dibenzothiazine derivatives and pharmaceutical compositions
Inventor: TOTH EDIT
IPC: A61K31/54
Filed: 1990-08-09
Abstract: The invention relates to 2-oxo-1-oxa-8-azaspiro [4,5] decane derivatives of formula (I), <CHEM>  wherein  X represents an oxygen atom or a NR group, wherein R represents a hydrogen atom or a C1-12 alkyl or C3-6cycloalkyl group, or a carbocyclic C6-10aryl or carbocylic C6-10aryl-C1-4alkyl group optionally substituted on the aromatic ring by one or more halogen atoms, C1-4 alkyl or C1-4alkoxy groups; R<1> and R<2> together represent a methylene group or when X is a >NR group, one of R<1> and R<2> may additionally represent a hydroxyl group and the other represent a methyl group; Z represents a hydrogen or halogen atom or a trihalomethyl or a C2-4alkanoyl group; and  n is 2 or 3; and all optical isomers and mixtures thereof and all acid addition and quarternary ammonium salts thereof. The invention further relates to pharmaceutical compositions containing these compounds and processes for their preparation. The compounds of formula (I) possess psychotropic and antiallergic properties and a low toxicity. Thus, they may be useful for the treatment of psychiatric and allergic diseases.
Patent NZ-241660-A (NZ)
Title: Controlled-release formulations overcoated with plasticised ethylcellulose and cured at elevated temperature and humidity
Inventor: OSHLACK BENJAMIN
IPC: A61K45/00
Filed: 1992-02-19
Abstract: A stabilized solid controlled release dosage form having a coating derived from an aqueous dispersion of ethylcellulose is obtained by overcoating a substrate including a therapeutically active with an aqueous dispersion of ethylcellulose and then curing the coated substrate at a temperature and relative humidity elevated to a suitable level above ambient conditions until the coated dosage form attains a stabilized dissolution profile substantially unaffected by exposure to storage conditions of elevated temperature and/or elevated relative humidity. <IMAGE>
Patent NZ-250750-A (NZ)
Title: Reacting gases in a slurry bed which contains a filtration zone to separate liquid product
Inventor: JAGER BEREND
IPC: C07C1/06
Filed: 1994-01-25
Abstract: A process and installation for producing liquid and, optionally, gaseous products from gaseous reactants comprises feeding gaseous reactants into a slurry bed (14) of solid particles suspended in a liquid; allowing the reactants to react as they pass upwardly through the slurry bed (14), thereby to form liquid and, optionally, gaseous products; and separating liquid product from the solid particles by passing, in a filtration zone (22) within the slurry bed (14), liquid product through a filtration medium (32) in a first direction, so that a cake of the solid particles forms on the filtration medium (32). The passage of liquid product through the filtering medium (32) is interrupted. The filtering medium (32) is then backflushed by passing a flushing fluid through the filtering medium (32) in a second direction, opposite to the first direction, for at least portions of the periods that the liquid product passage is interrupted, thereby to dislodge the cake from the filtering medium (32). <IMAGE>
Patent NZ-258690-A (NZ)
Title: Pyrrolopyrimidines and pharmaceutical compositions containing such compounds; intermediate pyrrole compounds
Inventor: CHEN YUHPYNG L
IPC: A61P1/00
Filed: 1993-11-12
Abstract: The compounds of the formulawherein R1, R2, R3, R4, R5 and R6 are as defined herein, are useful in the treatment of stress-related and other diseases. These compounds have corticotropin-releasing factor antagonist activity and as such are of use in the treatment of stress and anxiety related, and other disorders.
Patent NZ-263888-A (NZ)
Title: Fatty acid monoesters of various nucleoside and nucleoside analogues and derivatives; antiviral pharmaceutical compositions thereof
Inventor: BORRETZEN BERNT
IPC: A61P31/12
Filed: 1994-04-05
Abstract: PCT No. PCT/NO94/00071 Sec. 371 Date Nov. 29, 1995 Sec. 102(e) Date Nov. 29, 1995 PCT Filed Apr. 5, 1994 PCT Pub. No. WO94/22887 PCT Pub. Date Oct. 13, 1994A monoester compound of formula I:Nu-O-Fawherein O is oxygen, Nu is a nucleoside analog, Fa is an acyl group of a mono-unsaturated C18 or C20 omega-9 fatty acid, which fatty acid is esterified with a hydroxyl group in the 5'-position of the sugar moiety of the nucleoside analog or with a terminal hydroxyl group on the non-cyclic group of the nucleoside analog, and wherein Nu is represented by the formula II:B-Swherein S is a mono-saccharide derivative and B is a heterocyclic ring system.
Patent NZ-301500-A (NZ)
Title: Use of tomoxetine to treat attention-deficient/hyperactivity disorder (ADHD)
Inventor: HEILIGENSTEIN JOHN HARRISON
IPC: A61P25/14
Filed: 1996-01-04
Abstract: The specification describes the use of tomoxetine to treat attention-deficit/hyperactivity disorder (ADHD).  Tomoxetine is a well known drug, the chemical name of which is (R)-(-)-N-methyl-3-(2-methylphenoxy)-3-phenylpropylamine.
Patent NZ-311703-A (NZ)
Title: Suction box for a machine producing a web containing cellulose fibres comprises a chamber and suction inlet with ribs
Inventor: SOMERVUORI MARTTI
IPC: D21F3/10
Filed: 1996-07-04
Abstract: PCT No. PCT/FI96/00396 Sec. 371 Date Jan. 5, 1998 Sec. 102(e) Date Jan. 5, 1998 PCT Filed Jul. 4, 1996 PCT Pub. No. WO97/03246 PCT Pub. Date Jan. 30, 1997Suction box for a machine producing a web containing cellulose fibers, said suction box being placed inside a rotating suction roll (2) provided with a perforated jacket (1), said suction box (3) comprising a suction chamber (4) having a suction inlet (6) placed against the interior surface (5) of the suction roll and a suction connection (7) for creating a negative pressure in the suction chamber and sucking water through the perforations (8) in the suction roll into the suction chamber. The suction inlet (6) is provided with ribs (10) laid in a direction transverse to the direction of rotation (9) of the suction roll (2) and forming suction slits (11) in the longitudinal direction of the suction roll near the interior surface (5) of the suction roll.
Patent NZ-318559-A (NZ)
Title: Toothbrush handle having a head portion carrying or adapted to carry a bristle configuration
Inventor: BRADY JOAN
IPC: B25G1/10
Filed: 1996-08-09
Abstract: A toothbrush handle having a head position carrying or adapted to carry a bristle configuration, the handle having an end position, a waist, a shoulder portion and a neck connecting the shoulder to the head, the waist being narrower at least in plan view than the end portion or the shoulder and the end portion being rounded wherein the ratio of the maximum width of the end portion in plan view to the maximum width of the shoulder plan view is in the range 1.1:1 to 1.5:1, the end portion being thicker in side elevation than is the shoulder, and the ratio of the maximum thickness of the end position in side elevation to the maximum thickness of the shoulder in side elevation is the range of 1.1:1 to 1.7:1 is claimed.
Patent NZ-332310-A (NZ)
Title: Optionally condensed pyrimidine substituted hexahydro-pyrido[4,3-b]indole derivatives and medicaments
Inventor: KENNIS LUDO EDMOND JOSEPHINE
IPC: A61P43/00
Filed: 1997-05-15
Abstract: PCT No. PCT/EP97/02710 Sec. 371 Date Nov. 9, 1998 Sec. 102(e) Date Nov. 9, 1998 PCT Filed May 15, 1997 PCT Pub. No. WO97/44040 PCT Pub. Date Nov. 27, 1997This invention concerns the compounds of formula the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein Alk is C1-6alkanediyl; R1 is hydrogen, C1-6alkyl, aryl or aryl C1-6alkyl; R2, R3 and R4 are each independently selected from hydrogen, halo, hydroxy, nitro, cyano, C1-6alkyl, C1-6alkyloxy, trifluoromethyl, C1-6alkylthio, mercapto, amino, mono- and di(C1-6alkyl)amino, carboxyl, C1-6alkyloxycarbonyl or C1-6alkylcarbonyl; R5 is hydrogen, C1-6alkyl, phenyl or phenylC1-6alkyl; R6 is hydrogen, C1-6alkyl, C1-6alkyloxy, C1-6alkylthio, or a radical of formula -NR8R9, wherein R8 and R9 are each independently selected from hydrogen, C1-6alkyl, phenyl or phenylC1-6alkyl; R7 is hydrogen or C1-6alkyl; or R6 and R7 taken together may form a bivalent radical of formula -R6-R7-; having central dopamine and serotonin antogonistic activity; their preparation, compositions containing them and their use as a medicine.
Patent NZ-334404-A (NZ)
Title: L-trans-2-amino-4-(acetamidoethoxy)-3-butenoic acid also known as N-acetyl aminoethoxyvinylglycine and its use as an ethylene biosynthesis inhibitor
Inventor: HEIMAN DANIEL F
IPC: A01N37/46
Filed: 1997-09-22
Abstract: The compound L-trans-2-amino-4-(2-acetamidoethoxy)-3-butenoic acid or an ester or salt thereof is disclosed. L-trans-2-amino-4-(2-acetamidoethoxy)-3-butenoic acid is depicted above. A composition thereof is useful for inhibiting ethylene biosynthesis in a plant.
Patent NZ-334669-A (NZ)
Title: Apparatus and process for automatically transacting an expirationless option
Inventor: DAUGHTERY VERGIL L
IPC: G06F19/00
Filed: 1997-09-17
Abstract: A system and process for use in transacting an expirationless option on a particular asset is described. A user using a video display (220) is prompted to input data representative of a particular asset, the option type, an exercise price, the current price, the historic price volatility and the margin requirement for the particular asset. These data may be also obtained from a data source (130) and are later stored in a storage medium (250 or 350). This data is used in an algorithm for obtaining the option premium data for use in transacting the expirationless option. As shown in the figure each end user workstation 120 preferably includes a microprocessor 210, a video display 220 (e.g., a CRT projector or monitor), a keyboard 230, a mouse 240, a printer 260, and a storage medium 250 (e.g., a disk array, tape, optical drive, tape drive or floppy drive). The end user workstations 120 may be an IBM compatible PC, laptop, or pen computer running Microsoft Windows 95 or its equivalent.
Patent NZ-337578-A (NZ)
Title: Leukocyte elastase inhibitory activity by hydrophobic tetracycline
Inventor: SIMON SANFORD R
IPC: A61P29/00
Filed: 1998-02-26
Abstract: Use of a leukocyte elastase activity inhibitory amount of hydrophobic tetracycline in inhibiting excess leukocyte elastase activity in a susceptible biological system.
Patent NZ-338060-A (NZ)
Title: Use of bacterial cell wall extract for the manufacture of a medicament for treating a protozoal or parasitic disease
Inventor: ALKEMADE STANLEY J
IPC: A61K35/74
Filed: 1998-04-02
Abstract: Use of a bacterial cell wall extract in the manufacture of a medicament for treating a protozoal or a parasitic disease in an animal.
Patent NZ-502447-A (NZ)
Title: High speed, high resolution camera with an image reduction relay system
Inventor: BEACH ALLAN DAVID
IPC: G02B17/08
Filed: 1998-08-12
Abstract: A focal reducing lens system (5) reduces the image diameter of a conventional photographic objective lens system (2), so as to increase the relative aperture and hence the speed of the objective lens system (2).  A high-resolution image detector, such as a CCD sensor, may be placed at the focal plane (6) of the focal reducing lens system (5).  The focal reducing lens system (5) can be based on a modified Hawkins and Linfoot system including a meniscus lens (8) and a spherical mirror (7).  It may alternatively be based on Schmidt, Bouwers or Baker-Nunn lens systems.  System (5) has a characteristic first aperture (3) and a focus at a first focal surface (4).  A catadioptric focal reducing lens relay subsystem has a characteristic second aperture and a focus at a second focal surface having a characteristic image diameter.  The catadioptric focal reducing lens relay subsystem is arranged to reduce the image diameter of the photographic camera system.  The subsystems are arranged such that the relative aperture of the camera system is greater than the relative aperture of the photographic camper a subsystem considered alone.
Patent NZ-503978-A (NZ)
Title: A method and apparatus for measuring pulmonary blood flow by pulmonary exchange of oxygen and an inert gas with the blood
Inventor: ROBINSON GAVIN JOSEPH BRIAN
IPC: A61M16/04
Filed: 1997-10-24
Abstract: A method and apparatus is disclosed for measuring the pulmonary blood flow in a subject by isolating one or more divisions of the respiratory system (4,6,8) with a multi-lumen cuffed endobronchial catheter (1), the divisions (4,6,8) comprising of the complete gas exchange the respiratory system. The multi-lumen cuffed endobronchial catheter (1) includes two or more breathing systems and two or more gas delivery systems (9,10,11) to the isolated divisions of the respiratory system (4,6,8).  Each division is ventilated with a separate gas mixture where at least one gas mixture includes an inert soluble gas.  The pulmonary exchange of the inert soluble gas and oxygen in each of the divisions (4,6,8) and the end tidal concentration of the inert gas in at least two of the above mentioned divisions is used to calculate the pulmonary blood flow.
Patent NZ-506986-A (NZ)
Title: Temporary and/or emergency lighting system with inflatable bearing structure having at least one light at the top of the structure when inflated
Inventor: MEDICI GUIDO
IPC: F21S8/08
Filed: 1999-02-16
Abstract: A light stand has a light source 4 mounted at the top of an inflatable bearing structure 2 of superposed cylinders or cones of flexible material supported on a base 1 and inflated by a fan 6. The inflatable structure is internally divided into sections by bulkheads 2.1 with apertures 2.2 to ensure progressive and vertical inflation. A check valve 2.5 is provided near the bottom of the structure to prevent the structure from deflating rapidly if the fan should malfunction. A manually actuated valve 2.3 allows the structure to be deflated. The device may be self-contained, including a generator 5 for powering both for the fan motor and the light source.